Hot Stocks: Biodel Inc. (NASDAQ:BIOD), The Medicines Company (NASDAQ:MDCO), Novo Nordisk (NYSE:NVO), Dr. Reddy’s Laboratories (NYSE:RDY)

Biodel Inc., a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes, has signed a long-term manufacturing agreement with Cangene bioPharma Inc., a wholly-owned subsidiary of Emergent BioSolutions (Emergent) for development of its Glucagon Emergency Management (GEM) programme. Biodel Inc. (NASDAQ:BIOD) stock opened at $3.50 in last session, and closed at $3.28, while the day range of Biodel Inc. (NASDAQ:BIOD) stock is $3.26 – $3.50. The stock showed a positive weekly performance of 4.13%.

The Medicines Company (NASDAQ:MDCO) is scheduled to present at the 2014 Barclays Global Healthcare Conference in Miami, FL on March 12th at 1:00 PM Eastern Time. The Medicines Company (NASDAQ:MDCO) stock opened at $30.11 in last session, and closed at $29.87 by gaining 0.07%. The 52 week range of $28.00 – $41.28. Company’s market capitalization is $1.77 billion.

Roop was enrolled in a clinical trial testing a long-acting treatment for hemophilia B from Denmark’s Novo Nordisk A/S (ADR) (NYSE:NVO). The therapy is one of several new blood clotting agents in development that will help hemophilia patients cut by half, or more, the number of regular intravenous infusions they need to prevent traumatic bleeding in their daily lives. Novo Nordisk A/S (ADR) (NYSE:NVO) stock decreased -0.15% and finished the last session at $47.40. The EPS of the stock remained 1.74. Company’s market capitalization is $119.71 billion.

“Dr Reddys Laboratories is Limited (ADR) (NYSE:RDY) one of the few Indian conglomerates to have adapted well to the changing industry dynamics with special emphasis on research and technology. Promoted by the legendary Dr Anji Reddy, the company has many firsts to its name in the pharmaceuticals space.Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) stock opened the session at $44.75, and closed the session at $43.90. The 52 week range of the Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) stock remained $31.32 – $47.93 and the day range was $43.83 – $44.82.